Medirom Healthcare Valuation
| MRM Stock | USD 1.33 0.01 0.76% |
Today, the firm appears to be undervalued. Medirom Healthcare secures a last-minute Real Value of $2.26 per share. The latest price of the firm is $1.33. Our model forecasts the value of Medirom Healthcare from analyzing the firm fundamentals such as Current Valuation of 35.81 M, profit margin of 0.01 %, and Return On Equity of 0.53 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Medirom Healthcare's valuation include:
Price Book 6.6352 | Enterprise Value | Enterprise Value Ebitda 16.0242 | Price Sales 0.0013 | Trailing PE 3.4103 |
Undervalued
Today
Please note that Medirom Healthcare's price fluctuation is unstable at this time. Calculation of the real value of Medirom Healthcare is based on 3 months time horizon. Increasing Medirom Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medirom stock is determined by what a typical buyer is willing to pay for full or partial control of Medirom Healthcare Technologies. Since Medirom Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medirom Stock. However, Medirom Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.33 | Real 2.26 | Target 5.12 | Hype 1.18 |
The intrinsic value of Medirom Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medirom Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medirom Healthcare Technologies helps investors to forecast how Medirom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medirom Healthcare more accurately as focusing exclusively on Medirom Healthcare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Medirom Healthcare's intrinsic value based on its ongoing forecasts of Medirom Healthcare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Medirom Healthcare's closest peers.
Medirom Healthcare Cash |
|
About Medirom Healthcare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Medirom Healthcare Technologies. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medirom Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Medirom Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Medirom Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medirom Healthcare. We calculate exposure to Medirom Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medirom Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.6 B | 1.5 B | |
| Pretax Profit Margin | 0.01 | 0.01 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.24 | 0.19 |
Medirom Healthcare Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medirom Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.9 M | |
| Quarterly Earnings Growth Y O Y | 0.278 |
Medirom Healthcare Current Valuation Indicators
Medirom Healthcare's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Medirom Healthcare's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Medirom Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Medirom Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Medirom Healthcare's worth.When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Will Health Care Providers & Services sector continue expanding? Could Medirom diversify its offerings? Factors like these will boost the valuation of Medirom Healthcare. Expected growth trajectory for Medirom significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Medirom Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.278 | Earnings Share 0.39 | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
Understanding Medirom Healthcare requires distinguishing between market price and book value, where the latter reflects Medirom's accounting equity. The concept of intrinsic value - what Medirom Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Medirom Healthcare's price substantially above or below its fundamental value.
Understanding that Medirom Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medirom Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medirom Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.